[1
]
Affiliations of authors: Laboratory of Targeted Tumor Therapy, Key Laboratory of Systems
Biology, Shanghai Advanced Research Institute (QL, BP, CW, YZ, FG) Institute of Health
Sciences (YL, XC, BL, FG) Chinese Academy of Sciences, Shanghai, China; Department
of Neurosurgery, Renji Hospital (YQ,YL) Shanghai First People's Hospital (YG) and
Department of Radiation Oncology, Ruijin Hospital (CX), School of Medicine, Shanghai
Jiao-Tong University, Shanghai, China; Scripps Research Institute, La Jolla, CA (GFK,
TSE); Sorrento Thearpeutics, Inc, San Diego, CA (GFK); Department of Neuro-Oncology,
University of Texas, MD Anderson Cancer Center, Houston, TX (ZL); Cancer Research
Center, Shenzhen University, Shenzhen, China (DL); Shanghai Institute for Advanced
Immunochemical Studies, Shanghai Tech University, Shanghai, China (BJ).